NCT00347711撤回3 期
Bevacizumab and Retinal Vascular Occlusions
Asociación para Evitar la Ceguera en México2 个研究点 分布在 1 个国家开始时间: 2006年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 试验地点
- 2
研究概览
简要总结
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography
排除标准
- •Previous surgery
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein OcclusionMacular EdemaRetinal Vein OcclusionNCT00970957Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA107
终止
4 期
Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVOMacular EdemaCentral Retinal Vein OcclusionNCT00566761Asociación para Evitar la Ceguera en México10
Unknown
不适用
Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.NCT01707745Sivakami A Pai50
招募中
不适用
Treatment with bevacizumab for ocular vascular lesionsOcular vascular lesionsJPRN-UMIN000020916Keio University, School of Medicine1,000
已完成
不适用
Bevacizumab Treatment and Retinal Vessel MonitoringCancerNCT00740168Technische Universität Dresden20